Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Low bone mineral density (BMD) in HIV-infected individuals has been documented in an increasing number of studies. However, it is not clear whether it is the infection itself or the treatment that causes bone impairment. Microindentation measures bone material strength (Bone Material Strength index) directly. We recruited 85 patients, 50 infected with HIV and 35 controls. Median Bone Material Strength index was 84.5 (interquartile range 83-87) in HIV-infected patients and 90 (88.5-93) in controls (P < 0.001). No significant differences in BMD between cases and controls at any of the sites examined (total hip, femoral neck, and lumbar spine). HIV infection is associated with bone damage, independently of BMD.

Original publication

DOI

10.1097/QAI.0000000000000965

Type

Journal article

Journal

J acquir immune defic syndr

Publication Date

01/07/2016

Volume

72

Pages

314 - 318

Keywords

Absorptiometry, Photon, Adult, Anti-HIV Agents, Bone Density, Cross-Sectional Studies, Female, Femur Neck, HIV Infections, Humans, Lumbar Vertebrae, Male, Middle Aged, Osteoporosis, Risk Assessment, Spain